Loxo@Lilly Oncology Medical
@LoxoLillyOnc
Dedicated to communicating the latest science & innovation from Loxo@Lilly. Tweets intended for US oncology HCPs. See our community guidelines: https://t.co/1q8vAe63mK
ID:1508847230924562432
https://www.lilly.com/contact-us 29-03-2022 16:43:22
261 Tweets
5,1K Followers
633 Following
Follow People
Published in The Lancet Oncology, learn more about tumor-agnostic efficacy & safety of a selective RET inhibitor in pts w/ RET fusion-positive solid tumors other than lung or thyroid. #CancerResearch
View the results: e.lilly/3EuOfN7
Maryam Lustberg MD MPH @yalecancer @yalemed & Sandra Cuellar UIC Pharmacy join the CANCER BUZZ vodcast: bit.ly/3CFSRPa Tune in as our experts examine challenges with oral anti-cancer therapies & provide methods to better support patients: bit.ly/3EobaJY #cancer #podcast
'We see the disparities and want to change them.” A new Lilly education campaign focuses on Black women and their #breastcancer journey. Read about this innovative campaign: e.lilly/3SFMxw3 #WeAreLilly
We’re excited to join the #hematology community in Houston for Society of Hematologic Oncology (SOHO)’s 10th annual meeting! #SOHO22
If attending, be sure to stop by booth 150 & meet our medical team.
To learn more about our latest #bloodcancer research & pipeline, visit: e.lilly/3UA9na7
See results from a retrospective study investigating real-world overall survival in patients w/ metastatic #ColorectalCancer receiving an EGFR inhibitor as 2nd-line or 3rd-line treatment. #crcsm
Published in Future Oncology: e.lilly/3S7YIBp
Published in Advances in Therapy: See results from a retrospective cohort study on patients in Japan w/ recurrent #MantleCellLymphoma assessing real-world outcomes after BTK inhibitor discontinuation. #lymsm #MCL
View the study results: e.lilly/3Lgi4lJ
At #ESMO22 – SWOG Cancer Research Network is presenting exploratory analysis from Lung-MAP S1800A, a study investigating OS w/ a VEGFR2 inhibitor + a PD1 inhibitor in pts w/ advanced #NSCLC following progression on prior ICI & platinum chemotherapy. #LCSM
View presentation: e.lilly/3DcaGWw